Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study

European Psychiatry

Volumn 24, Issue 8, 2009, Pages 501-506

  Jager M ^a,b   Schmauss M ^c   Laux, G ^d   Pfeiffer, H ^e   Naber, D ^f   G Schmidt, L ^g   Gaebel, W ^h   Klosterkotter J ⁱ   Heuser, I ^j   Maier, W ^k   Lemke, M R ^l   Degner, D ^m   Buchkremer, G ⁿ   Gastpar, M ^o   Moller H J ^a   Riedel, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY HOSPITAL AUGSBURG   (Germany)

^d Inn Salzach Hospital   (Germany)

^e Isar Amper Hospital   (Germany)

^f UNIVERSITY OF HAMBURG   (Germany)

^g JOHANNES GUTENBERG UNIVERSITY   (Germany)

^h HEINRICH HEINE UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF COLOGNE   (Germany)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k UNIVERSITY OF BONN   (Germany)

^l Rheinische Kliniken   (Germany)

^m UNIVERSITY OF GÖTTINGEN   (Germany)

ⁿ UNIVERSITY OF TÜBINGEN   (Germany)

^o UNIVERSITY OF DUISBURG ESSEN   (Germany)

more..

Author keywords

Antipsychotics; Schizophrenia

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REMISSION; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; AREA UNDER CURVE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; PATIENT SELECTION; PSYCHIATRIC STATUS RATING SCALES; ROC CURVE; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRANQUILIZING AGENTS; TREATMENT OUTCOME;

EID: 70649094031     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2009.02.005     Document Type: Article

References (34)

1. Agid O., Kapur S., Arenovich T., and Zipursky R.B. Delayed-onset hypothesis of antipsychotic action. A hypothesis tested and rejected. Arch Gen Psychiatry 60 (2003) 1228-1234
2. Andreasen N.C., Carpenter Jr. W.T., Kane J.M., Lasser R.A., Marder S.R., and Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162 (2005) 441-449
3. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia 2nd edition. Washington DC: American Psychiatric Association; 2004.
4. Ascher-Svanum H., Nyhuis A.W., Faries D.E., Kinon B.J., Baker R.W., and Shekhar A. Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia. Schizophr Bull 34 (2008) 1163-1171
5. Bartko G., Herczeg I., and Bekesy M. Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement. J Clin Psychiatry 48 (1987) 363-365
6. Carlsson A., and Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 20 (1963) 140-144
7. Chang Y.C., Lane H.Y., Yang K.H., and Huang C.L. Optimizing early prediction for antipsychotic response in schizophrenia. J Clin Psychopharmacol 26 (2006) 554-559
8. Corell C.U., Malhotra A.K., Kaushik S., McMeniman M., and Kane J.M. Early prediction of antipsychotic response in schizophrenia. Am J Psychiatry 160 (2003) 2063-2065
9. Crespo-Facorro B., Pelayo-Terán J.M., Pérez-Iglesias R.P., Ramírez-Bonilla M.L., Mártinez-García O., Pardo-García G., et al. Predictors of acute treatment response in patients with a first episode of non-affective psychosis: Sociodemographics, premorbid and clinical variables. J Psychiatr Res 41 (2007) 659-666
10. Emsley R., Rabinowitz J., and Medori R. Time course for antipsychotic treatment response in first-episode schizophrenia. Am J Psychiatry 163 (2006) 743-745
11. Falkai P., Wobrock T., Lieberman J., Glenthoi B., Gattaz W.F., and Möller H.J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines of biological treatment of schizophrenia. Part 1: acute treatment of schizophrenia. World J Biol Psychiartry 6 (2006) 132-191
12. Gaebel W. Prediction of response to acute neuroleptic treatment in schizophrenia. Int Clin Psychopharmacol 11 Suppl. 2 (1996) 47-54
13. Jäger M., Bottlender R., Strauss A., and Möller H.J. Classification of functional psychoses and its implication for prognosis: Comparison between ICD-10 and DSM-IV. Psychopathology 37 (2004) 110-117
14. Jäger M., Riedel M., Messer T., Laux G., Pfeiffer H., Naber D., et al. Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders. Eur Arch Psychiatry Clin Neurosci 257 (2007) 47-53
15. Jäger M, Riedel M, Schmauß M, Laux G, Pfeiffer H, Naber D, et al. Prediction of symptom remission in schizophrenia during inpatient treatment. World J Biol Psychiatry 2007. DOI: 10.1080/15622970701541054.
16. Kay SR. Positive and negative syndromes in schizophrenia: Assessment and research. Clinical and experimental psychiatry monography No. 5. New York, NY: Brunner/Mazel; 1991.
17. Kapur S., Arenovich T., Agid O., Zipursky R., Lindborg S., and Jones B. Evidence of onset of antipsychotic effects within the first 24 hours of treatment. Am J Psychiatry 162 (2005) 939-946
18. Kinon B.J., Chen L., Ascher-Svanum H., Stauffer V.L., Kollack-Walker S., Sniadecki J.L., et al. Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia. Schizophr Res 102 (2008) 230-240
19. Lambert M., Naber D., Eich F.X., Schacht M., Linden M., and Schimmelmann B.G. Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride. Acta Psychiatr Scand 115 (2007) 106-113
20. Leucht S., Busch R., Hamann J., Kissling W., and Kane J.M. Early-onset hypothesis of antipsychotic drug action: a hypothesis tested confirmed and extended. Biol Psychiatry 57 (2005) 1543-1549
21. Leucht S., Bush R., Kissling W., and Kane J. Early prediction of antipsychotic nonresponse among patients with schizophrenia. J Clin Psychiatry 68 (2007) 352-360
22. Leucht S., Shamsi S.A., Bush R., Kissling W., and Kane J.M. Predicting antipsychotic drug response - replication and extension to six weeks in an international olanzapine study. Schizophr Res 101 (2008) 312-319
23. Lin C.H., Chou L.S., Lin C.H., Hsu C.Y., Chen Y.S., and Lane H.Y. Early prediction of clinical response in schizophrenia patients receiving atypical antipsychotic zotepine. J Clin Psychiatry 68 (2007) 1522-1527
24. May P.R., van Putten T., and Yale C. Predicting outcome of antipsychotic drug treatment from early response. Am J Psychiatry 137 (1980) 1088-1089
25. Möller H.J., Kissling W., and Zerssen v.D. The prognostic value of early response of schizophrenic patients to neuroleptics concerning the following course of treatment. Pharmacopsychiatria 16 (1983) 46-49
26. Möller H.J., Hohe-Schramm M., Cording-Tömmel C., Schmid-Bode W., Wittchen H.U., Zaudig M.V., et al. The classification of functional psychoses and its implications for prognosis. Br J Psychiatry 154 (1989) 467-472
27. National Institute for Clinical Excellence. Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care. London: NICE; 2002.
28. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005;39:1-30.
29. Seeman P., and Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 188 (1975) 1217-1219
30. Stern R.G., Kahn R.S., Harvey P.D., Amin F., Apter S.H., and Hirschowitz J. Early response to haloperidol treatment in chronic schizophrenia. Schizophr Res 10 (1993) 265-271
31. Weinstein M.C., and Fineberg H.V. Clinical Decision Analysis (1980), WB Saunders, Philadelphia
32. WHO. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva: WHO; 1993.
33. Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M. Strukturiertes klinisches Interview für DSM-IV (SKID). Göttingen: Hogrefe; 1997.
34. Wölwer W., Buchkremer G., Häfner H., Klosterkötter J., Maier W., Möller H.J., et al. German research network on schizophrenia. Bridging the gap between research and care. Eur Arch Clin Neurosci 253 (2003) 321-329